Stay updated with breaking news from Mitchell Kapoor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore Halozyme Therapeutics' promising financial outlook up to 2028. Discover revenue forecasts, earnings projections, and market insights.
Operator: Good day and thank you for standing by. Welcome to the CytomX Therapeutics Third Quarter 2023 Financial Results. At this time, all participants are in a listen only-mode.
Legend Biotech Corporation's (NASDAQ: LEGN) partner, Johnson & Johnson (NYSE: JNJ), reported Q3 Carvykti revenues of $152 million,
Century Therapeutics, Inc. (NASDAQ: IPSC) reported weaker-than-expected second-quarter results.
HC Wainwright has initiated coverage on Halozyme Therapeutics Inc (NASDAQ: HALO) with a Buy rating and a